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Abstract Acetohydroxyacid synthase (AHAS; EC 4.1.3.18)
contains catalytic and regulatory subunits, the latter being
required for sensitivity to feedback regulation by leucine, valine
and isoleucine. The regulatory subunit of Arabidopsis thaliana
AHAS possesses a sequence repeat and we have suggested
previously that one repeat binds leucine while the second binds
valine or isoleucine, with synergy between the two sites. We
have mutated four residues in each repeat, based on a model of
the regulatory subunit. The data confirm that there are separate
leucine and valine/isoleucine sites, and suggest a complex
pathway for regulatory signal transmission to the catalytic
subunit. ß 2002 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
The ¢rst few steps in the biosynthesis of leucine, valine and
isoleucine follow a common pathway in which the ¢rst reac-
tion is catalysed by acetohydroxyacid synthase (AHAS; EC
4.1.3.18) [1,2]. This enzyme catalyses the decarboxylation of
pyruvate followed by reaction with either pyruvate or 2-keto-
butyrate to form 2-acetolactate or 2-aceto-2-hydroxybutyrate,
respectively.
Bacterial AHAS is composed of two large subunits that
contain the catalytic machinery, and two smaller regulatory
subunits. The regulatory subunit is required for full catalytic
activity and for sensitivity to feedback inhibition by the
branched-chain amino acids. In agreement with earlier predic-
tions [3] a similar subunit arrangement has now been estab-
lished in eukaryotic AHAS, ¢rst in yeast [4] and later in plants
[5,6].
An unusual feature of plant AHAS is that it is inhibited by
all three of the branched-chain amino acids, unlike most bac-
terial and fungal enzymes that are sensitive to valine only.
Moreover, there is synergistic inhibition by the combination
of leucine plus valine. These properties are observed for the
plant enzyme extracted from its native source [7] as well as
that reconstituted in vitro using the puri¢ed Arabidopsis thali-
ana subunits expressed in Escherichia coli [6]. The synergistic
inhibition has been linked to the observation that the A. thali-
ana AHAS regulatory subunit amino acid sequence shows
clear evidence of an internal duplication. We have suggested
that the protein contains two domains with one binding valine
(or isoleucine) and the other leucine [6]. The evidence for a
leucine-speci¢c site is that reconstitution of the catalytic sub-
unit with the one domain of the regulatory subunit yields an
enzyme that is inhibited by leucine but not by valine or iso-
leucine. The second domain cannot bind leucine because sat-
uration with leucine should abolish the e¡ects of valine (or
isoleucine) whereas it is observed that saturation with leucine
enhances the a⁄nity for valine. A molecular model of the
A. thaliana AHAS regulatory subunit was proposed based
on the regulatory domain of threonine deaminase (EC
4.2.1.16), which also contains an internal duplication that cre-
ates separate binding sites for its regulators valine and isoleu-
cine [8].
In this paper we have tested this model by mutating four of
the residues in each of the repeats of the A. thaliana AHAS
regulatory subunit. The data show that each mutation produ-
ces similar e¡ects on inhibition by valine and isoleucine while
the e¡ects on leucine inhibition are not correlated. These re-
sults support the proposal that one site binds valine or iso-
leucine and the other binds leucine. However, it appears that
the two regulator sites are not solely contained within one
repeat but may be located at the interface between two do-
mains. This ¢nding is in agreement with a proposed model for
the bacterial enzyme [9] in which the interface involves a reg-
ulatory subunit dimer. The plant regulatory subunit displays
an inherent asymmetry as judged by the observation that mu-
tation of the equivalent residue in each repeat does not result
in reciprocal e¡ects on the inhibition. The data suggest a
complex pathway for transmission of inhibitory signals within
the regulatory subunit and across to the catalytic subunit.
2. Materials and methods
Materials and experimental procedures were as described previously
[6], except as noted below. Methods for bacterial culture and DNA
manipulation generally followed standard procedures [10]. Mutations
were introduced by PCR using the megaprimer method [11]. Oligo-
nucleotides were designed to introduce or remove a restriction enzyme
recognition site to aid identi¢cation of mutated DNA. All constructs
were tested by diagnostic restriction enzyme digestion and con¢rmed
by DNA sequencing using the Prism Ready Dye Terminator Cycle
Sequencing kit and DNA Sequencer 373A (Perkin-Elmer Applied Bio-
systems, Norwalk, CT, USA).
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Enzyme inhibition data were analysed by ¢tting to them the equa-
tion:
X  X o13p=100  p=100=1 I=Kappi 
where X is the measured rate, [I] is the inhibitor concentration, Xo is
the rate in the absence of inhibitors, p is the percent inhibition at
saturating inhibitor concentration and Kappi is the apparent inhibition
constant. Fitting was performed using the GraFit program (Erithacus
Software Ltd., Horley, UK) to obtain best estimates and standard
errors for the parameters Xo, p and K
app
i .
3. Results and discussion
Comparison of various known or presumed AHAS regula-
tory subunit sequences has identi¢ed a region that shows a
high degree of conservation (Fig. 1A). A glycine residue (G98
and G331 in the ¢rst and second repeats, respectively, of the
A. thaliana protein) is totally conserved except in E. coli
AHAS isoenzyme II where it is a glutamate. This E. coli
AHAS isoform is valine-insensitive and it has been shown
that mutation of the corresponding glycine to aspartate in
E. coli AHAS isoenzyme III [9] and Streptomyces cinnamonen-
sis AHAS [12] abolishes valine inhibition. Another residue
that is invariant in all of the proteins except E. coli AHAS
isoenzyme II is N113/N346 and this residue has been mutated
to histidine in E. coli AHAS isoenzyme III [9] resulting in a
loss of valine sensitivity.
In our molecular model of the A. thaliana AHAS regulatory
subunit (Fig. 1B) G98 is close to N346 in the other repeat
and, similarly, G331 is close to N113. Two residues £anking
these in space are F107/F340 and Y112/Y345. While these
residues are not totally conserved in AHAS regulatory subunit
sequences, they are each invariably aromatic or large hydro-
phobic residues.
These observations led us to perform mutation studies on
each of the residues shown in Fig. 1B. Apart from the glycine
residues, each was mutated to alanine and N346 in repeat 2
was also mutated to histidine, as found in the valine-insensi-
tive E. coli AHAS isoenzyme II. G98 was changed to a glu-
Fig. 1. Structure of the AHAS regulatory subunit. Panel A shows an alignment of the highly conserved section of the known and presumed
AHAS regulatory subunit protein sequences. The plant (Ath1 and Ath2, A. thaliana repeats 1 and 2; Npl1 and Npl2, Nicotiana plumbaginifolia
repeats 1 and 2) are shown ¢rst. Other sequences are arranged in alphabetical order by species abbreviation. These abbreviations are: Aae,
Aquifex aeolicus ; Afu, Archaeoglobus fulgidus ; Bap, Buchnera aphidicola ; Bsu, Bacillus subtilis ; Cca, Cyanidium caldarium ; Ccr, Caulobacter
crescentus ; Cgl, Corynebacterium glutamicum ; Cme, Cyanidioschyzon merolae ; Eco1, E. coli isozyme I; Eco2, E. coli isozyme II; Eco3, E. coli
isozyme III; Gth, Guillardia theta ; Hin, Haemophilus in£uenzae ; Lla, Lactococcus lactis ; Mae, Methanococcus aeolicus ; Mav, Mycobacterium
avium ; Mja, Methanococcus jannaschii ; Mle, Mycobacterium leprae ; Mth, Methanobacterium thermoautotrophicum ; Mtu, Mycobacterium tubercu-
losis ; Ncr, Neurospora crassa ; Ppu, Porphyra purpurea ; Sav, Streptomyces avermitilis ; Sce, Saccharomyces cerevisiae ; Sci, S. cinnamonensis ;
Sma, Schizosaccharomyces malidevorans ; Spa, Saccharomyces pastorianus ; Spo, Schizosaccharomyces pombe ; Ssp, Synechocystis sp; Sty3, Salmo-
nella typhimurium isozyme III; Tma, Thermotoga maritima. The arrows indicate the four positions mutated in the present study and those high-
lighted in red are residues that are conserved in all sequences except for E. coli isozyme II. Those highlighted in yellow are invariably large hy-
drophobic residues. Panel B shows a molecular model of the A. thaliana AHAS regulatory subunit. The structure shown is that of the
regulatory domain of E. coli threonine deaminase (PDB accession code 1TDJ). This structure was modi¢ed by mutation at the eight residues
shown using the Swiss-PdbViewer (http://au.expasy.org/spdbv/). The resulting coordinate ¢le was visualised using WebLab Viewer Pro (http://
www.accelrys.com/viewer/), which was used to create the ¢nal diagram in conjunction with POV-Ray (http://www.povray.org).
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tamate (cf. E. coli AHAS isoenzyme II) while G331 was mu-
tated to aspartate (cf. E. coli AHAS isoenzyme III and S.
cinnamonensis mutants).
Each mutated regulatory subunit is capable of activating
the A. thaliana catalytic subunit, as illustrated for the
N113A variant in Fig. 2A. Due to the limited solubility of
the regulatory subunit it is not possible to achieve 100% re-
constitution. However, for all variants, su⁄cient regulatory
subunit was added to stimulate the activity by at least
5-fold. These reconstituted enzymes were then tested for inhi-
bition by each of the branched-chain amino acids, as well as
by an equimolar mixture of valine plus leucine (Fig. 2B). The
apparent inhibition constants (Kappi ) obtained from these ex-
periments are summarised in Table 1. In all cases, saturation
with the inhibitor results in some residual activity; the percent
inhibition at saturation is also reported in Table 1 and ranges
from 15 to 73% of the uninhibited rate. The percent inhibition
by valine plus leucine is invariably similar to that obtained by
either valine or leucine alone, whichever is greatest.
A range of e¡ects was observed varying from complete
abolition of inhibition by all branched-chain amino acids
(F107A) to an enzyme that is very similar to wild-type
(Y345A). In all cases, the e¡ects on valine and isoleucine in-
hibition are similar, insofar as any changes in the Kappi values
are both in the same direction when compared to the wild-
type value. However, there is no correlation with the e¡ects
on leucine inhibition. For example, the G98E change increases
the potency of valine and isoleucine without a¡ecting inhibi-
tion by leucine. The Y112A variant exhibits exactly the oppo-
site pattern, increasing the potency of leucine without a¡ect-
ing inhibition by valine and isoleucine. There is a marked
asymmetry in the results ; for example, the F340A mutation
interferes with valine and isoleucine inhibition but has no
e¡ect on leucine. If there was symmetry, the F107A mutation
would be expected to a¡ect leucine inhibition only whereas it
actually abolishes inhibition by all of the branched-chain ami-
no acids.
As we have described previously for AHAS reconstituted
with the wild-type regulatory subunit, there is synergy be-
tween inhibition by the combination of leucine plus valine.
If there was no synergy, an equimolar mixture of these two
amino acids would be expected to result in a Kappi value that is
the harmonic mean of the values for the two individual amino
acids. For wild-type, this harmonic mean is 274 þ 23 WM
Table 1
Inhibition of A. thaliana AHAS reconstituted using wild-type catalytic subunits and variants of the regulatory subunit
Regulatory
subunit
Kappi (percent inhibition)
Leucine (mM) Isoleucine (mM) Valine (mM) Leucine+valine (WM) Harmonic mean (WM)
Wild-type 0.34 þ 0.03 (63 þ 1) 1.38 þ 0.16 (63 þ 2) 0.23 þ 0.03 (45 þ 3) 12.3 þ 2.3 (59 þ 2) 274 þ 23
Repeat 1
G98E 0.30 þ 0.03 (19 þ 1) 0.37 þ 0.16 (15 þ 1) 0.033 þ 0.006 (26 þ 1) 139 þ 44 (28 þ 2) 59 þ 10
F107A NI NI NI NI s 2U104
Y112A 0.08 þ 0.01 (42 þ 1) 1.26 þ 0.40 (35 þ 3) 0.26 þ 0.03 (21 þ 1) 19.9 þ 1.7 (47 þ 1) 122 þ 12
N113A 0.45 þ 0.11 (41 þ 3) NI NI 323 þ 64 (46 þ 2) W900
Repeat 2
G331D NI NI NI 557 þ 132 (50 þ 2) s 2U104
F340A 0.39 þ 0.11 (57 þ 2) 3.72 þ 1.76 (73 þ 17) 1.28 þ 0.30 (38 þ 3) 14.7 þ 1.2 (57 þ 4) 598 þ 133
Y345A 0.44 þ 0.08 (72 þ 3) 1.30 þ 0.18 (60 þ 3) 0.12 þ 0.02 (31 þ 1) 10.8 þ 1.9 (69 þ 2) 189 þ 26
N346A 1.11 þ 0.23 (61 þ 7) 0.42 þ 0.08 (40 þ 4) 0.009 þ 0.002 (29 þ 2) 32.9 þ 8.6 (55 þ 4) 17.9 þ 4.0
N346H 1.03 þ 0.16 (51 þ 2) 0.46 þ 0.22 (35 þ 3) 0.020 þ 0.004 (36 þ 1) 45.1 þ 5.1 (54 þ 1) 39.2 þ 7.7
NI, less than 10% inhibition at the highest concentration tested; 5 mM for individual amino acids and 10 mM total for the leucine plus valine
combination.
Fig. 2. Kinetic properties of A. thaliana AHAS reconstituted using
wild-type catalytic subunits and the N113A variant of the regulatory
subunit. Panel A shows the e¡ect on activity of reconstitution by
varying concentrations of the N113A variant of the regulatory sub-
unit. The di¡erent symbols represent two independent experiments
and were normalised to a common value of 1.0 for the activity of
the catalytic subunit alone. Panel B shows the inhibition of the re-
constituted enzyme by leucine alone (b), valine alone (a), or an
equimolar mixture of leucine plus valine (E). Data for the e¡ect of
isoleucine alone have been omitted for clarity but are similar to
those obtained for valine.
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(Table 1) compared to the observed value of 12.3 þ 2.3 WM.
Table 1 lists these calculated harmonic means from which it
can be seen that synergy cannot be detected simply by com-
paring the Kappi value of a mutant for leucine plus valine with
that of the wild-type. For example, N113A has a Kappi value of
323 þ 64 WM that is markedly elevated compared to wild-type.
However, the expected value based on no synergy would be
approximately 900 WM because valine is not inhibitory. An
opposite example is seen for the corresponding mutation in
repeat 2 (N346A). In this case, the Kappi value for the combi-
nation is not greatly elevated relative to wild-type. However,
valine alone is a very strong inhibitor so in fact synergy is
abolished in this variant.
A simpli¢ed summary of the inhibition results and a sche-
matic model that attempts to explain these data are shown in
Fig. 3. The regulatory subunit contains two domains corre-
sponding to the two repeats, with separate binding sites for
leucine (site L) and for valine/isoleucine (site VI) at the do-
main interface. There are separate and reciprocal signalling
pathways that promote regulator binding at one site when
the other is occupied. In addition, occupancy of either site
by its ligand is signalled to a common centre that then triggers
inhibition of the catalytic activity. The proposal for this com-
mon centre is based on the observation that the extent of
inhibition is similar for leucine alone and for the leucine
plus valine combination.
The G98E mutation does not a¡ect leucine inhibition, pro-
motes valine/isoleucine binding, and interferes with synergy.
These results suggest that this mutation is mimicking site L
occupancy and must be switching on the signal from site L to
site VI. A similar e¡ect is observed for the two N346 mutants,
except that leucine inhibition is somewhat impaired, suggest-
ing that N346 may form part of site L. It is of interest that
G98 and N346 ful¢l similar roles despite being well separated
in the primary sequence and located in di¡erent repeats. How-
ever, these results are entirely consistent with the molecular
model (Fig. 1B), which puts these two residues in close prox-
imity. The complementary pair of mutations, G331D and
N113A, also have similar e¡ects to one another except that
one (G331D) interferes with leucine inhibition while the other
does not; again, this supports the molecular model. However,
the e¡ects of these mutations are not complementary to those
at the G98/N346 pair. G331D prevents inhibition by any of
the amino acids suggesting that it is involved in signal trans-
mission to the catalytic subunits. N113A prevents valine and
isoleucine inhibition but does not a¡ect leucine; this would be
consistent with either a role in site VI, or in signalling to the
common centre. However, there is some evidence of synergy
that would favour the explanation that N113 is more involved
in signalling to the common centre than having a direct role in
site VI.
Changing Y345 to alanine has no detectable e¡ect; how-
ever, the corresponding change in repeat 1 (Y112A) promotes
leucine binding while retaining some synergy. These results
would be consistent with partial activation of the site VI to
site L signalling pathway. The ¢nal pair of mutations, at F107
and F340, again exhibit a disparate e¡ect. F340A has similar
e¡ects to N113A suggesting that it too is involved in signal-
ling to the common centre. In contrast, F107A is completely
insensitive to all of the branched-chain amino acids, similar to
the results for the G331D variant.
The results presented here are, super¢cially, somewhat at
variance with the model and data for the equivalent aspara-
gine mutation in E. coli AHAS isoenzyme III [9]. However, it
should be noted that for that enzyme it is a regulatory subunit
dimer with two equivalent valine-speci¢c sites that corre-
sponds to the paired repeats of the A. thaliana subunit. There-
fore, a single site mutation in the bacterial protein should be
compared with a double mutant of the plant AHAS.
Although we have not constructed this double mutant, it
would be predicted that changing both asparagine residues
to histidines would a¡ect both sites and the double mutant
would be insensitive to all of the branched-chain amino acids.
This would agree with the observation that the single aspar-
agine mutation in E. coli AHAS isoenzyme III strongly de-
creases valine inhibition [9].
These mutation studies reveal that the regulation of A.
thaliana AHAS is far more complex than we originally sup-
posed. A mutation that disrupted site L only would be ex-
pected to prevent inhibition by leucine, leave inhibition by
valine and isoleucine una¡ected, and to abolish synergy.
Fig. 3. Simpli¢ed summary of the inhibition results and a schematic
model for the regulatory interactions in A. thaliana AHAS. Panel A
summarises the e¡ects (Table 1) of the inhibitors. The symbol ‘ = ’
indicates a Kappi value between 0.5 and 1.5 times that of the wild-
type, while ‘u’ and ‘s’ denote e¡ects outside this range resulting in
increased or decreased inhibition, respectively. The presence (Y) or
absence (N) of synergy was estimated by comparing the actual Kappi
value for the leucine plus valine combination with the harmonic
mean of the individual Kappi values for these two compounds. Panel
B shows a schematic model for the regulatory interactions. The bi-
lobed regulatory subunit has separate site binding leucine (site L) or
valine/isoleucine (site VI) at the interface between the two domains.
The dotted arrows show signalling pathways. Occupancy of either
site signals to the other site (curved arrows), resulting in increased
a⁄nity for its ligand. Site occupancy also generates signals (vertical
arrows) that are transmitted to a common centre (boxed) and then
(horizontal arrow) to the catalytic subunits.
FEBS 25742 8-2-02 Cyaan Magenta Geel Zwart
Y.-T. Lee, R.G. Duggleby/FEBS Letters 512 (2002) 180^184 183
None of the mutations produces this pattern. Similarly, none
of the mutations produces a pattern that is consistent with
disruption of site VI only. The mutations mainly a¡ect trans-
mission of site occupancy signals between sites, from one of
the sites to the common centre, or to the catalytic subunit.
The model that we have proposed is necessarily speculative
in that it is derived from a molecular model based on an
entirely di¡erent protein. While this model may be broadly
correct, it is undoubtedly approximate in detail. Further prog-
ress in understanding the precise role of the residues that we
have mutated must await experimental determination of the
three-dimensional structure of this protein.
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